Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles in Trials & Approvals

Ascletis Approved to Start China Trial of PD-L1 to Cure HIV-1
Everest Reports ADC Meets Endpoint for Triple-Negative Breast Cancer
Gmax Starts China Phase I Trial of 2nd Gen Obesity Therapy
IASO Starts China Phase I/II Trial of CD19/CD22 CAR-T for Lymphoma
Nanjing's TransThera Granted US Fast Track for Cholangiocarcinoma Therapy
ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China